Publications scientifiques
Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).
-
Fibrose pulmonaire - FPI 02/08/23
Air pollution and poverty: a deadly mix in idiopathic pulmonary fibrosis ?
Eur Respir J. 2021 Aug 12:2101714.
-
Fibrose pulmonaire - FPI 02/08/23
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal ?
Front Med (Lausanne). 2021 Aug 5;8:713698.
-
Fibrose pulmonaire - FPI 02/08/23
Usefulness of Body Composition CT Analysis in Patients with Idiopathic Pulmonary Fibrosis : A Pilot Study
Acad Radiol. 2021 Aug 17: S1076-6332(21)00328-7.
-
Fibrose pulmonaire - FPI 02/08/23
Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial
Eur Respir J. 2021 Jul 8;58(1):2001518.
-
Fibrose pulmonaire - FPI 02/08/23
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover
Respir Med. 2021 Jul;183:106415.
-
Fibrose pulmonaire - FPI 02/08/23
Response to letter entitled: Re: Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis
Eur J Cancer. 2021 Jul;151:252-253.
-
Fibrose pulmonaire - FPI 02/08/23
Prevalence, predicting factors and impact of internet use by patients with idiopathic pulmonary fibrosis: A cross-sectional observational study
Respir Med Res. 2021 May;79:100818.
-
Fibrose pulmonaire - FPI 02/08/23
Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis
Eur J Cancer. 2021 Mar;145:179-182.
-
Fibrose pulmonaire - FPI 02/08/23
Regulation of immune cells in lung fibrosis: the reign of regnase-1 ?
Eur Respir J. 2021 Mar 11;57(3):2004029.
-
Fibrose pulmonaire - FPI 02/08/23
Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation
Eur Respir J. 2021 Feb 11;57(2):2003198.